SCHEMBL3147190

SCHEMBL3147190

COc1cnc2ncccc2c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
NPC1 O15118 1/20 0.42
HSP90AA1 P07900 1/20 0.42
LMNA P02545 2/20 0.41
MAOB P27338 2/20 0.41
SYK P43405 2/20 0.41
NSD2 O96028 1/20 0.40
CASP6 P55212 1/20 0.40
G6PD P11413 1/20 0.40
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
PDE5A O76074 2/20 0.38
AURKA O14965 1/20 0.38
IGF1R P08069 1/20 0.37
PLAU P00749 1/20 0.37
BRD4 O60885 1/20 0.36
HTT P42858 2/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GRM5 P41594 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3152669 0.83 PDE5A (0.43) L3MBTL1NPC1HSP90AA1LMNAMAOB
SCHEMBL30940274 0.77 SYK (0.49) MAOBSYKNSD2CASP6G6PD
SCHEMBL19036712 0.77 SYK (0.49) MAOBSYKNSD2CASP6G6PD
SCHEMBL3143662 0.77 CCR1 (0.54) L3MBTL1NPC1HSP90AA1LMNAHTT
SCHEMBL3148928 0.77 ERN1 (0.41) NPC1LMNAMAOBSYKNSD2
SCHEMBL15415344 0.77 XIAP (0.40) L3MBTL1NPC1HSP90AA1LMNAMAOB
SCHEMBL3151611 0.74 HSP90AA1 (0.45) L3MBTL1NPC1HSP90AA1LMNABRD4
SCHEMBL3160999 0.74 PDPK1 (0.53) LMNAPDGFRBPDGFRAABCG2HSD17B10
SCHEMBL3147594 0.74 HSP90AA1 (0.45) L3MBTL1NPC1HSP90AA1LMNAHTT
SCHEMBL3147218 0.73 MAPT (0.54) L3MBTL1NPC1HSP90AA1LMNASYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2233493-A1 Macrolides Pfizer Products Inc. (US) 2010-09-29 EP disclosed
EP-1836211-B1 MACROLIDES PFIZER PROD INC (US) 2010-03-03 EP disclosed
US-7462600-B2 Macrolides PFIZER INC (US) 2008-12-09 US disclosed
EP-1836211-A1 MACROLIDES Pfizer Products Incorporated (US) 2007-09-26 EP disclosed
WO-2006067589-A1 MACROLIDES PFIZER PRODUCTS INC. (US) 2006-06-29 WO disclosed
US-20060135447-A1 Macrolides CHUPAK LOUIS S 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135447-A1 Macrolides LCAT, NOP2, HDAC6 L3MBTL1 1344/4885NPC1 16/4885HSP90AA1 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.